{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T09:12:19Z","timestamp":1788340339692,"version":"build-2803163510"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.compbiomed.2020.103749","type":"journal-article","created":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T10:54:37Z","timestamp":1586602477000},"page":"103749","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":132,"special_numbering":"C","title":["COVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles\u2019 heel conserved region to minimize probability of escape mutations and drug resistance"],"prefix":"10.1016","volume":"121","author":[{"given":"B.","family":"Robson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiomed.2020.103749_bib1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0065-3527(06)66005-3","article-title":"The molecular biology of coronaviruses","volume":"66","author":"Masters","year":"2006","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.compbiomed.2020.103749_bib2","author":"Lu"},{"key":"10.1016\/j.compbiomed.2020.103749_bib3","doi-asserted-by":"crossref","first-page":"103670","DOI":"10.1016\/j.compbiomed.2020.103670","article-title":"Computers and viral diseases. Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus","author":"Robson","year":"2020","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.compbiomed.2020.103749_bib4","series-title":"Preliminary Bioinformatics Studies on the Design of Synthetic Vaccines and Preventative Peptidomimetic Antagonists against the Wuhan Seafood Market Coronavirus. Possible Importance of the KRSFIEDLLFNKV Motif","author":"Robson","year":"2020"},{"issue":"1","key":"10.1016\/j.compbiomed.2020.103749_bib5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, function, and evolution of coronavirus spike proteins","volume":"3","author":"Li","year":"2016","journal-title":"Annual Reviews in Virology"},{"issue":"11","key":"10.1016\/j.compbiomed.2020.103749_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0007870","article-title":"Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro published","volume":"4","author":"Kam","year":"2009","journal-title":"PloS One"},{"key":"10.1016\/j.compbiomed.2020.103749_bib7","doi-asserted-by":"crossref","unstructured":"Belouzard, S., Chu, V. C. and Whittaker, G. R., Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites, Proc. Natl. Acad. Sci., 106(14, 5871-5876; https:\/\/doi.org\/10.1073\/pnas.0809524106 (last accessed 1\/26\/2020).","DOI":"10.1073\/pnas.0809524106"},{"key":"10.1016\/j.compbiomed.2020.103749_bib8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/cr.2016.152","article-title":"Entity 1 containing Chain A, B, C SARS-CoV spike glycoprotein","volume":"27","author":"Gui","year":"2017","journal-title":"Cell Res."},{"issue":"12","key":"10.1016\/j.compbiomed.2020.103749_bib9","article-title":"Peptides corresponding to the predicted heptad repeat 2 domain of the feline coronavirus spike protein are potent inhibitors of viral infection","volume":"8","author":"Liu","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.compbiomed.2020.103749_bib10","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1038\/srep14480","article-title":"The heptad repeat region is a major selection target in MERS-CoV and related coronaviruses","volume":"5","author":"Forni","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiomed.2020.103749_bib11","first-page":"2580","article-title":"Coronavirus escape from heptad repeat 2 (HR2)-Derived peptide entry inhibition as a result of mutations in the HR1 domain of the spike fusion protein","author":"Berend","year":"2008","journal-title":"Journal of Virology, March"},{"key":"10.1016\/j.compbiomed.2020.103749_bib12","series-title":"Introduction to Proteins and Protein Engineering","author":"Robson","year":"1998"},{"key":"10.1016\/j.compbiomed.2020.103749_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10989-016-9534-8","article-title":"Peptides as \u2018drugs\u2019: the journey so far","volume":"23","author":"Sachdeva","year":"2017","journal-title":"Int. J. Pept. Res. Therapeut."},{"key":"10.1016\/j.compbiomed.2020.103749_bib14","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3390\/vaccines2030515","article-title":"Peptide Vaccine: Progress and Challenges","volume":"vol. 2","author":"Li","year":"2014","journal-title":"Vaccines"},{"issue":"325","key":"10.1016\/j.compbiomed.2020.103749_bib15","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/325395a0","article-title":"Prediction of HIV vaccine","volume":"4","author":"Robson","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.compbiomed.2020.103749_bib16","series-title":"Synthetic Peptides Related to HIV-Env Proteins","author":"Fishleigh","year":"1990"},{"key":"10.1016\/j.compbiomed.2020.103749_bib17","series-title":"Synthetic Polypeptides Derived from the HIV Envelope Glycoprotein","author":"Fishleigh","year":"1995"},{"key":"10.1016\/j.compbiomed.2020.103749_bib18","series-title":"Fragments of Prion Proteins","author":"Fishleigh","year":"1995"},{"key":"10.1016\/j.compbiomed.2020.103749_bib19","series-title":"Fragments of Prion Proteins","author":"Fishleigh","year":"1998"},{"key":"10.1016\/j.compbiomed.2020.103749_bib20","author":"Citywire"},{"key":"10.1016\/j.compbiomed.2020.103749_bib21","author":"Robson"},{"key":"10.1016\/j.compbiomed.2020.103749_bib22","first-page":"B9","article-title":"Computer aided peptide and protein engineering","volume":"vol. 1","author":"Robson","year":"1986"},{"issue":"7","key":"10.1016\/j.compbiomed.2020.103749_bib23","first-page":"9","article-title":"The EPSITRON concept of peptide and protein engineering. Applications of computer-aided molecular design\u201d","volume":"1","author":"Robson","year":"1986","journal-title":"Chem. Des. Autom. News"},{"key":"10.1016\/j.compbiomed.2020.103749_bib24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0263-7855(87)80038-3","article-title":"An expert system for protein engineering. Its application in the study of chloramphenicol acetyltransferase and avian pancreatic polypeptide","volume":"5","author":"Robson","year":"1987","journal-title":"J. Mol. Graph."},{"issue":"4","key":"10.1016\/j.compbiomed.2020.103749_bib25","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0014-5793(87)80060-1","article-title":"Studies on rationales for an expert system approach to the analysis of protein sequence data - preliminary analysis of the human epidermal growth factor receptor","volume":"2","author":"Fishleigh","year":"1987","journal-title":"FEBS Lett."},{"key":"10.1016\/j.compbiomed.2020.103749_bib26","series-title":"Mod\u00e9lisation des polypeptides: application aux oligopeptides vaccinants\u201d INRA\/EUC Rapport FRT - 85 T 0606","author":"Garnier","year":"1988"},{"key":"10.1016\/j.compbiomed.2020.103749_bib27","series-title":"Chemical Information Systems - beyond the Structure Diagrams","first-page":"107","article-title":"A polymorphic programming environment for the chemical pharmaceutical and biotechnology industries","author":"Ball","year":"1990"},{"key":"10.1016\/j.compbiomed.2020.103749_bib28","series-title":"Theoretical Biochemistry and Molecular Biophysics 2 Proteins","first-page":"207","article-title":"Computer aided design of biomolecules: the big hammer approach","author":"Robson","year":"1992"},{"key":"10.1016\/j.compbiomed.2020.103749_bib29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF00117275","article-title":"PRO_LIGAND: an approach to de novo molecular design. 1. Application to the design of organic molecules","volume":"9","author":"Clark","year":"1995","journal-title":"J. Comp.Aided.Mol.Des."},{"key":"10.1016\/j.compbiomed.2020.103749_bib30","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1021\/jm00049a019","article-title":"PRO_LIGAND: an approach to de novo design. 2. Design of novel molecules from molecular field analysis (MFA) models and pharmacophores","volume":"37","author":"Waszkowycz","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiomed.2020.103749_bib31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00124404","article-title":"PRO_LIGAND: an approach to de novo molecular design. 3. A genetic algorithm for structure refinement","volume":"9","author":"Westehad","year":"1995","journal-title":"B. J. Comp.A ided. Mol. Des."},{"key":"10.1016\/j.compbiomed.2020.103749_bib32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF00124453","article-title":"PRO_LIGAND: an approach to de novo molecular design. 4. Application to the design of peptides, D. Frenkel, D. E. Clark, J. Li, C. W. Murray, B. Robson, B. Waszkowycz and D. R. Westhead. (1995)","volume":"9","author":"Frenkel","year":"1995","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"10","key":"10.1016\/j.compbiomed.2020.103749_bib33","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s00894-018-3820-7","article-title":"Receptor pharmacophore ensemble (REPHARMBLE): a probabilistic pharmacophore modeling approach using multiple protein-ligand complexes","volume":"24","author":"Kumar","year":"2018","journal-title":"J. Mol. Model."},{"issue":"12","key":"10.1016\/j.compbiomed.2020.103749_bib34","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1016\/j.compbiomed.2013.09.010","article-title":"Suggestions for a web based universal exchange and inference language for medicine\u201d","volume":"43","author":"Robson","year":"2013","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.compbiomed.2020.103749_bib35","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.compbiomed.2015.07.015","article-title":"Implementation of a web based universal exchange and inference language for medicine. Sparse data, probabilities and inference in data mining of clinical data repositories","volume":"66","author":"Robson","year":"2015","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.compbiomed.2020.103749_bib36","first-page":"299","article-title":"Studies in using a universal exchange and inference language for evidence based medicine","volume":"79","author":"Robson","year":"2016","journal-title":"Semi-Automated Learning and Reasoning for PICO Methodology, Systematic Review, and Environmental Epidemiology\u201d, Computers in Biology and Medicine"},{"key":"10.1016\/j.compbiomed.2020.103749_bib37","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.compbiomed.2018.02.013","article-title":"Studies in the extensively automatic construction of large odds-based inference networks from structured data. Examples from medical, bioinformatics, and Health insurance Claims data","volume":"95","author":"Robson","year":"2018","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.compbiomed.2020.103749_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2020.103621","article-title":"Extension of the Quantum Universal Exchange Language to precision medicine and drug lead discovery. Preliminary example studies using the mitochondrial genome","volume":"117","author":"Robson","year":"2020","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.compbiomed.2020.103749_bib39","author":"The Biology Workbench"},{"key":"10.1016\/j.compbiomed.2020.103749_bib40","unstructured":"U.S. National Library of Medicine, National center for biotechnology information, national institutes of Health, BLASTP SUITEhttps:\/\/blast.ncbi.nlm.nih.gov\/Blast.cgi (last accessed 1\/28\/2020)."},{"key":"10.1016\/j.compbiomed.2020.103749_bib41","series-title":"The GOR Method for Predicting Secondary Structure in Proteins\u201din 'Prediction of Protein Structure and the Principles of Protein Conformation","first-page":"417","author":"Garnier","year":"1989"},{"issue":"3","key":"10.1016\/j.compbiomed.2020.103749_bib43","article-title":"Synthesis of angiotensin-converting enzyme (ACE) inhibitors: an important class of antihypertensive drugs","volume":"22","author":"De Lima","year":"1999","journal-title":"Quim. Nova"},{"issue":"8","key":"10.1016\/j.compbiomed.2020.103749_bib44","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0167-7799(99)01339-6","article-title":"Beyond proteins","volume":"17","author":"Robson","year":"1999","journal-title":"Trends Biotechnol."},{"issue":"suppl. 1","key":"10.1016\/j.compbiomed.2020.103749_bib45","article-title":"Chemical synthesis and activity of D, superoxide dismutase","volume":"5","author":"Figliozzi","year":"1996","journal-title":"Protein Sci."},{"key":"10.1016\/j.compbiomed.2020.103749_bib46","series-title":"Pseudoproteins: Non-protein Protein-like Machines, the Sixth Foresight Conference on Molecular Nanotechnology","author":"Robson","year":"1998"},{"issue":"5","key":"10.1016\/j.compbiomed.2020.103749_bib47","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/cbdd.13472","article-title":"Peptide and protein mimetics by retro and retroinverso analogs","volume":"93","author":"Rai","year":"2019","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.compbiomed.2020.103749_bib48","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1126\/science.7367882","article-title":"Monte Carlo simulation of water behaviour around the dipeptide N-acetylalanyl-N'methylamide","volume":"208","author":"Hagler","year":"1980","journal-title":"Science"},{"key":"10.1016\/j.compbiomed.2020.103749_bib49","series-title":"The Biophysics of Water","first-page":"66","article-title":"Some views of solvation effects in the light of a Monte Carlo simulation","author":"Robson","year":"1982"},{"issue":"5","key":"10.1016\/j.compbiomed.2020.103749_bib50","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10822-011-9429-x","article-title":"Drug discovery using very large numbers of patents: general strategy with extensive use of match and edit operations","volume":"25","author":"Robson","year":"2011","journal-title":"J. Computer Aided Molecular Design"},{"key":"10.1016\/j.compbiomed.2020.103749_bib51","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jbi.2014.11.003","article-title":"An overview of bioinformatics tools for epitope prediction: implications on vaccine development","volume":"53","author":"Soria-Guerr","year":"2015","journal-title":"J. Biomed. Inf."},{"key":"10.1016\/j.compbiomed.2020.103749_bib52","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1747-0285.2009.00825.x","article-title":"Advantages of a synthetic peptide immunogen over a protein immunogen in the development of an anti-pilus vaccine for Pseudomonas aeruginosa","volume":"74","author":"Kao","year":"2009","journal-title":"Chem. Biol. Drug Des."},{"issue":"826","key":"10.1016\/j.compbiomed.2020.103749_bib53","article-title":"Epitope discovery and synthetic vaccine design","volume":"9","author":"Palatnik-de-Sousa1","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.compbiomed.2020.103749_bib54","author":"Grifoni"},{"key":"10.1016\/j.compbiomed.2020.103749_bib55","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00127-20","article-title":"An analysis based on decade-long structural studies of SARS 3","author":"Wan","year":"2020","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.compbiomed.2020.103749_bib56","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jmb.2004.09.032","article-title":"Dissecting and designing inhibitor selectivity determinants at the S1 site using an artificial Ala190 protease (Ala190 uPA)","volume":"344","author":"Katz","year":"2004","journal-title":"J. Mol. Biol."},{"issue":"6","key":"10.1016\/j.compbiomed.2020.103749_bib57","article-title":"Different residues in the SARS-CoV spike protein determine cleavage and activation by the host cell protease TMPRSS2","volume":"12","author":"Lennart","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.compbiomed.2020.103749_bib58","article-title":"Cleavage specificity analysis of six type II transmembrane serine proteases (TTSPs) using PICS with proteome-derived peptide libraries","volume":"9","author":"Barr\u2019e","year":"2014","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.compbiomed.2020.103749_bib59","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.antiviral.2006.04.014","article-title":"Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction","volume":"74","author":"Ho","year":"2007","journal-title":"Antivir. Res."},{"issue":"1","key":"10.1016\/j.compbiomed.2020.103749_bib60","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.antiviral.2011.02.008","article-title":"Emodin inhibits current through SARS-associated coronavirus 3a protein","volume":"90","author":"Schwarz","year":"2011","journal-title":"Antivir. Res."},{"issue":"14","key":"10.1016\/j.compbiomed.2020.103749_bib61","doi-asserted-by":"crossref","first-page":"8017","DOI":"10.1128\/JVI.00998-13","article-title":"Novel inhibitors of severe acute respiratory syndrome coronavirus entry that act by three distinct mechanisms","volume":"87","author":"Adedeji","year":"2013","journal-title":"J. virology"},{"issue":"1","key":"10.1016\/j.compbiomed.2020.103749_bib62","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1476-5381.2010.00826.x","article-title":"Emodin, a natural product, selectively inhibits 11\u03b2-hydroxysteroid dehydrogenase type 1 and ameliorates metabolic disorder in diet-induced obese mice","volume":"161","author":"Feng","year":"2010","journal-title":"British Journal of J Pharmacology"},{"key":"10.1016\/j.compbiomed.2020.103749_bib63","article-title":"Hydrophobicity and hydrophilicity of steroid binding sites","volume":"vol. 27","author":"Westphal","year":"1986"},{"key":"10.1016\/j.compbiomed.2020.103749_bib64","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/v11010063","article-title":"Exploring the papillomaviral proteome to identify potential candidates for a chimeric vaccine against cervix papilloma using immunomics and computational structural vaccinology","volume":"11","author":"Kaliamurthi","year":"2019","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.compbiomed.2020.103749_bib65","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/cbdd.13602","article-title":"Prediction and validation of potent peptides against herpes simplex virus type 1 via immunoinformatic and systems biology approach","volume":"94","author":"Mehmood","year":"2019","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.compbiomed.2020.103749_bib66","article-title":"DTI-CDF: a cascade deep forest model towards the prediction of drug-target interactions based on hybrid features","volume":"152","author":"Chu","year":"2019","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.compbiomed.2020.103749_bib67","series-title":"CytoMegaloVirus Infection Database: A Public Omics Database for Systematic and Comparable Information of CMV","author":"Kaushik","year":"2019"},{"key":"10.1016\/j.compbiomed.2020.103749_bib68","article-title":"A-CaMP: a tool for anti-cancer and antimicrobial peptide generation","author":"Kaushik","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"1","key":"10.1016\/j.compbiomed.2020.103749_bib69","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jtcme.2018.02.001","article-title":"Mechanism & inhibition kinetics of bioassay-guided fractions of Indian medicinal plants and foods as ACE inhibitors","volume":"9","author":"Khan","year":"2019","journal-title":"J. Tradit., Complementary . Med."},{"issue":"3","key":"10.1016\/j.compbiomed.2020.103749_bib71","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1096\/fj.11-193557","article-title":"Misdirected antibody responses against an N-terminal epitope on human rhinovirus VP1 as explanation for recurrent RV infections","volume":"26","author":"Niespodziana","year":"2011","journal-title":"Faseb. J."},{"issue":"12","key":"10.1016\/j.compbiomed.2020.103749_bib72","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1096\/fj.06-5910fje","article-title":"Cooperative molecular and cellular networks regulate Toll-like receptor-dependent inflammatory responses","volume":"20","author":"Morris","year":"2006","journal-title":"Faseb. J."},{"issue":"35","key":"10.1016\/j.compbiomed.2020.103749_bib73","first-page":"E5192","article-title":"p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1","volume":"113","author":"Ma-Lauer","year":"2016"},{"key":"10.1016\/j.compbiomed.2020.103749_bib74","doi-asserted-by":"crossref","unstructured":"M. Hoffmann, H. Kleine-Weber, S. Schroeder, N. Kr\u00fcger, T. Herrler, N-H. Nai-Huei Wu, M.A. M\u00fcller, C. Drosten, S. Stefan P\u00f6hlmann, SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor, Cell Press, Available online 5 March 2020. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052.","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"10.1016\/j.compbiomed.2020.103749_bib75","author":"Di Guardo"},{"key":"10.1016\/j.compbiomed.2020.103749_bib76","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jcim.9b01165","article-title":"STACKED \u2013 Solvation theory of aromatic complexes as key for estimating drug binding","author":"Loeffler","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.compbiomed.2020.103749_bib77","first-page":"139","article-title":"The jenneration of disease: vaccination, romanticism, and revolution","volume":"39","author":"Fulford","year":"2000"},{"issue":"2","key":"10.1016\/j.compbiomed.2020.103749_bib78","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"2203","author":"Hamming","year":"2004","journal-title":"J. Pathol."},{"issue":"7","key":"10.1016\/j.compbiomed.2020.103749_bib79","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1124\/dmd.118.081083","article-title":"11\u03b2-Hydroxysteroid dehydrogenase 1 human tissue distribution, selective inhibitor, and role in doxorubicin","volume":"46","author":"Yang","year":"2018","journal-title":"Drug Metabol. Dispos."},{"issue":"6","key":"10.1016\/j.compbiomed.2020.103749_bib80","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1210\/en.2005-1621","article-title":"A novel promoter for the 11\u03b2-hydroxysteroid dehydrogenase type 1 gene is active in lung and is C\/EBP\u03b1 Independent,Charlotte Bruley, val lyons, alan G. F. Worsley, margaret D. Wilde, gretchen D. Darlington, nik M. Morton, jonathan R. Seckl, karen E. Chapman","volume":"147","author":"Bruley","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.compbiomed.2020.103749_bib81","series-title":"Angiotensin Receptor Blockers as Tentative SARS-CoV-2 Therapeutics","author":"Gurwitz","year":"2020"}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482520301281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482520301281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T19:24:34Z","timestamp":1757877874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482520301281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":79,"alternative-id":["S0010482520301281"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2020.103749","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles\u2019 heel conserved region to minimize probability of escape mutations and drug resistance","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2020.103749","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103749"}}